Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking method to diabetes management. These innovative therapies function by mimicking the natural actions of GLP-1, a hormone released by the gut https://thebookpage.com/story6233908/reta-glucagon-like-peptide-1-receptor-agonists